Assembly Biosciences is advancing a new class of oral therapeutics for the treatment of hepatitis B (HBV) infection and novel oral live biotherapeutics for disorders associated with the microbiome.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Nov 17, 2020 at 2:55 PM EST
Nov 13 - Nov 16, 2020
Nov 5, 2020 at 4:30 PM EST